ClinicalTrials.gg
Drug

Tapentadol clinical trials

Also written Nucynta, Palexia and CG5503 IR.

studies test it
61
open now
1
in phase 3
34
first study started
2003

How each study uses Tapentadol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tapentadol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Nov 2008 · NUCYNTA · NDA 022304 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tapentadol
13
Tapentadol Prolonged Release
5
Yantil®
4
tapentadol (CG5503) ER 50-mg TRF
3
Tapentadol Hydrochloride
2

Brand

Nucynta
10
Palexia
9

Development codes

CG5503 IR
4
JNS024ER
1

Studies by the year they started

60 studies that test it; most in 2007 (10)

Studies that test Tapentadol, by start year
YearStudies
20031
20042
20051
20064
200710
20085
20096
20107
20117
20123
20132
20141
20154
20172
20181
20211
20231
20242

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
10
Phase 3
34
Phase 4
9
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 50 · Other 11

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (20) · Grünenthal GmbH (19) · Janssen Research & Development, LLC (3) · Ortho-McNeil Janssen Scientific Affairs, LLC (3) · Janssen Pharmaceutical K.K. (3) · All India Institute of Medical Sciences, Bhubaneswar (2) · ISSSTE Hospital Regional "Gral. Ignacio Zaragoza" (1) · Shaukat Khanum Memorial Cancer Hospital & Research Centre (1)

Often tested with

Tested in the same studies.

Oxycodone (3) · Tramadol (2)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Tapentadol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 61

See all 61 studies that test Tapentadol →

Given beside what is tested · 1 — Tapentadol is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Tapentadol

Codes

What other systems call Tapentadol · ClinicalTrials.gg INT006725

  • MeSH (NLM) D000077432TapentadolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) H8A007M585TAPENTADOLConfirmed FDA, NLM, Wikidata
  • RxNorm 787390Confirmed FDA, Wikidata
  • Wikidata Q414463tapentadolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C72139TapentadolOne source FDA
  • DrugBank DB06204One source Wikidata

Also registered as tapentadol hydrochloride (UNII 71204KII53 · RxNorm 857492).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.